Development by UCLA-led research team works to keep blood sugar at normal levels
UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes.
The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.
Insulin is a hormone naturally produced in the pancreas. It helps the body regulate glucose, which is consumed through food and provides the body with energy.
Diabetes occurs when a person’s body does not naturally produce insulin (Type 1 diabetes), or does not efficiently use the insulin that is produced (Type 2). In either case, a regular dosage of insulin is prescribed to manage the disease, which affects more than 400 million people worldwide.
Generally, people who need to use insulin monitor their blood sugar levels with a glucose meter or continuous glucose monitoring system and then calculate their insulin dose accordingly. In addition, a regular carbohydrate intake is important to keep the blood sugar levels normal. Both of these requirements are necessarily subject to human error, which can have potentially devastating consequences.
An overdose of insulin can cause hypoglycemia, when blood sugar is too low. That could lead to seizures, coma, and in extreme cases, death.
As a safety check, the UCLA-led team has developed a type of “smart” insulin, called i-insulin, that can prevent blood sugar levels from dipping too low.
Inside the body, insulin acts as a “key” to help glucose get into cells from the bloodstream. When insulin attaches to a cell’s surface, it activates a protein inside the cell, called glucose transporter, which then makes its way to the cell’s surface. This molecule then brings the surrounding glucose from the blood into the cell.
The research team added an additional molecule to insulin to create the new smart insulin. This added molecule, called a glucose transporter inhibitor, chemically blocks the glucose transporter molecule that has come to the surface. Its presence doesn’t block all glucose from entering, nor does it permanently block the transporter molecules. Instead, it’s part of a dynamic process that depends on how many inhibitor and glucose molecules are present.
“Our new i-insulin works like a ‘smart’ key,” said the study’s principal investigator Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering. “The insulin lets glucose get into the cell, but the added inhibitor molecule prevents too much from going in when blood sugar is normal. This keeps blood sugar at normal levels and reduces the risk of hypoglycemia.”
“This i-insulin can also rapidly respond to high glucose levels,” added Jinqiang Wang, the study’s co-lead author and a postdoctoral researcher in Gu’s research group. “For example, after a meal, when glucose levels climb, the insulin level in the bloodstream also quickly increases, which helps normalize the glucose level.”
The UCLA-led research team tested the smart insulin on mice with Type 1 diabetes. The i-insulin controlled glucose levels within the normal range for up to 10 hours after a first injection. A second injection three hours later extended the protection from hypoglycemia.
“The next step is to further evaluate the long-term biocompatibility of the modified insulin system in an animal model before determining whether to move to clinical trials,” said co-author Dr. John Buse, a professor and director of the Diabetes Care Center at the University of North Carolina School of Medicine. “The vision, if realized, would be one of the most exciting advances in diabetes care.”
“The new insulin has the potential to be optimized for response times and how long it could last in the body before another dose would be required,” Gu said. “And it could be delivered in other methods, such as a skin patch with tiny needles, or in pills.”
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Coronavirus offers new challenges to people trying to manage diabetes and kidney diseaseon May 11, 2020 at 3:00 am
During the coronavirus outbreak, people with conditions like diabetes and kidney disease are adapting their medical routines to avoid exposure.
- Jazz station 91.9/WCLK-FM morning host Morris Baxter on medical leave over diabeteson May 9, 2020 at 11:10 pm
Baxter said in a press release he wants to get the word out that people should get tested for diabetes and help change the way the world views diabetes - especially for people of ...
- Teen Obesity and Type 2 Diabetes Both Tied to Early Signs of Heart Diseaseon May 9, 2020 at 5:04 pm
Adolescents with obesity and type 2 diabetes have damage in their blood vessels that usually isn’t seen until later in life and that may help explain their increased risk for cardiovascular disease in ...
- Sidra Medicine treatment protocol for hybrid insulin pump for Type 1 diabeteson May 9, 2020 at 5:00 pm
Dr Goran Petrovski Sidra Medicine, a member of Qatar Foundation, has successfully established its Type 1 diabetes (T1D) treatment protocol, based on the effective use of an insulin pump, for children ...
- Diabetes hotline receives over 1,800 calls in April: HMCon May 9, 2020 at 5:00 pm
Samra and Dr Mahmoud Zirie. Doha In March, Hamad Medical Corporation’s (HMC) diabetes care team extended the hours of operation for its diabetes hotline in response to the Covid-19 pandemic, and ...
- People with Diabetes May Be Having Fewer Heart Attacks, Strokeson May 9, 2020 at 5:52 am
Experts say better medications as well as changes in lifestyle habits could be factors in reducing cardiovascular events among people with diabetes.
- COMMENTARY: The Links Between COVID-19 and Diabetes, Known and Unknownon May 8, 2020 at 2:17 pm
Dr Harpreet Bajaj summarizes the known and unknown links between diabetes and COVID-19, focusing on three clinical questions.
- Secrets of Being a Mom with Diabeteson May 8, 2020 at 3:14 am
Type 1 diabetes is a full-time job. And you only have to live with it for a day or two to realize it will impact every single part of your life. In fact, real life with type 1 diabetes often feels ...
- Diabetes Patients Face Serious COVID-19 Complicationson May 7, 2020 at 9:41 pm
Diabetes may amplify the effects of coronavirus. It's important for diabetics to avoid infection and to manage their blood sugar levels vigilantly.
- Travis Stork of 'The Doctors' says it's important to 'control your diabetes' — now, more than everon May 7, 2020 at 11:08 am
Of the millions of adults who have diabetes, more than 7 million are undiagnosed, the ADA reports. “The most likely symptom is nothing,” Stork says. “It’s pretty scary.” ...
via Bing News